BiomX (HLSQ) Stock Overview
A holding company, focuses on defense, security, and critical infrastructure technologies. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
HLSQ Community Fair Values
Create NarrativeSee what 8 others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
BiomX Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$1.27 |
| 52 Week High | US$122.93 |
| 52 Week Low | US$0.98 |
| Beta | 1.34 |
| 1 Month Change | -14.36% |
| 3 Month Change | -76.31% |
| 1 Year Change | -98.59% |
| 3 Year Change | -99.82% |
| 5 Year Change | -99.90% |
| Change since IPO | -99.90% |
Recent News & Updates
Recent updates
Regulatory Tailwinds And Antimicrobial Resistance Focus Will Support Long Term Phage Therapy Potential
Catalysts About BiomX BiomX is a clinical stage company developing precision bacteriophage therapies targeting difficult bacterial infections. What are the underlying business or industry changes driving this perspective?What Kind Of Shareholders Own BiomX Inc. (NYSEMKT:PHGE)?
If you want to know who really controls BiomX Inc. ( NYSEMKT:PHGE ), then you'll have to look at the makeup of its...Shareholder Returns
| HLSQ | US Biotechs | US Market | |
|---|---|---|---|
| 7D | -14.0% | -5.9% | -2.2% |
| 1Y | -98.6% | 34.6% | 13.1% |
Return vs Industry: HLSQ underperformed the US Biotechs industry which returned 34.6% over the past year.
Return vs Market: HLSQ underperformed the US Market which returned 13.1% over the past year.
Price Volatility
| HLSQ volatility | |
|---|---|
| HLSQ Average Weekly Movement | 15.7% |
| Biotechs Industry Average Movement | 9.6% |
| Market Average Movement | 6.9% |
| 10% most volatile stocks in US Market | 15.4% |
| 10% least volatile stocks in US Market | 2.9% |
Stable Share Price: HLSQ's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: HLSQ's weekly volatility has decreased from 29% to 16% over the past year, but is still higher than 75% of US stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2015 | 20 | Mikey Oster | www.biomx.com |
BiomX Inc., a holding company, focuses on defense, security, and critical infrastructure technologies. The company’s portfolio targets various niches, such as counter-drone systems, AI-enabled command-and-control, perimeter and border security, wide-area surveillance, and aerial firefighting. It serves defense agencies, prime contractors, transportation operators, municipalities, and critical infrastructure providers.
BiomX Inc. Fundamentals Summary
| HLSQ fundamental statistics | |
|---|---|
| Market cap | US$4.94m |
| Earnings (TTM) | -US$45.50m |
| Revenue (TTM) | US$332.00k |
Is HLSQ overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| HLSQ income statement (TTM) | |
|---|---|
| Revenue | US$332.00k |
| Cost of Revenue | US$235.00k |
| Gross Profit | US$97.00k |
| Other Expenses | US$45.60m |
| Earnings | -US$45.50m |
Last Reported Earnings
Jun 30, 2026
Next Earnings Date
n/a
| Earnings per share (EPS) | -17.03 |
| Gross Margin | 29.22% |
| Net Profit Margin | -13,704.82% |
| Debt/Equity Ratio | 7.6% |
How did HLSQ perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/09/11 00:02 |
| End of Day Share Price | 2026/09/11 00:00 |
| Earnings | 2026/06/30 |
| Annual Earnings | 2025/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
BiomX Inc. is covered by 1 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Joseph Pantginis | H.C. Wainwright & Co. |